Examination of the effect of hyposensitization therapy by sweat and Malassezia antigen

Examination of the effect of hyposensitization therapy by sweat and Malassezia antigen - Hyposensitization therapy by sweat and Malassezia antigen

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018787

Enrollment

Registered

2015-09-01

Start date

2015-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis and cholinergic urticaria

Interventions

hyposensitization therapy by sweat antigen or Malassezia antigen

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with atopic dermatitis or cholinergic urticaria 2. No change of treatment within one month. 3. Patients who can visit our clinic reguraly. 4. Patients who are 12 years old or more and 80 years or less. 5. Patients who can sign a contract. 6. Patients who have allergy to sweat antigen or Malassezia antigen.

Exclusion criteria

Exclusion criteria: 1. Patients who have unstable symptoms. 2. Patients who have history of strong allergy against food or dust or etc. 3. Patients who are pregnant or have possibility of pregnancy. 4. Patients with severe primary disease like severe arteriosclerosis, severe hypertension and heart failure. 5. Patients who are seemed to impertinent by a responsible person.

Design outcomes

Primary

Measure	Time frame
Improvement of ich and skin symptoms on heating load test	—

Countries

Japan

Contacts

Public ContactShunsuke Takahagi

Hiroshima University Hospital Dermatology

takshuns@gmail.com082-257-5237

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026